Alport Syndrome Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 66 pages | ID: A8B56E3F4366EN
Market Monitor Global

Abstracts

Alport Syndrome is the hereditary genetic disorder characterized by glomerulonephritis, abnormal vision, acute hearing loss and end-stage renal disease. Alport Syndrome is also called the hereditary nephritis.

This report contains market size and forecasts of Alport Syndrome Treatment in Global, including the following market information:

Global Alport Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Alport Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Angiotensin Converting Enzyme (ACE) Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Alport Syndrome Treatment include Pfizer, Johnson?Johnson, Abbott, Sanofi, Bayer, Merck, Novartis, AstraZeneca and Eli Lilly and Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alport Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Alport Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Alport Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)

• Angiotensin Converting Enzyme (ACE) Inhibitor
• Angiotensin Receptor Blockers (ARB’s)
• Diuretic
• Others

Global Alport Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Alport Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Alport Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Alport Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Alport Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Alport Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Johnson?Johnson
• Abbott
• Sanofi
• Bayer
• Merck
• Novartis
• AstraZeneca
• Eli Lilly and Company
• GlaxoSmithKline
• Teva Pharmaceutical Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Alport Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Alport Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALPORT SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Alport Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Alport Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Alport Syndrome Treatment Players in Global Market
3.2 Top Global Alport Syndrome Treatment Companies Ranked by Revenue
3.3 Global Alport Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Alport Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alport Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alport Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Alport Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Alport Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Alport Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Angiotensin Converting Enzyme (ACE) Inhibitor
  4.1.3 Angiotensin Receptor Blockers (ARB’s)
  4.1.4 Diuretic
  4.1.5 Others
4.2 By Type - Global Alport Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Alport Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Alport Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Alport Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Alport Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Alport Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Alport Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Alport Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Alport Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Alport Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Alport Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Alport Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Alport Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Alport Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Alport Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Alport Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Alport Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Alport Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Alport Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Alport Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Alport Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Alport Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Alport Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Alport Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Alport Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Alport Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Alport Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Alport Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Alport Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Alport Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Alport Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Alport Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Alport Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Alport Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Alport Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Alport Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Alport Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Alport Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Alport Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Alport Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Alport Syndrome Treatment Major Product Offerings
  7.1.4 Pfizer Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Johnson?Johnson
  7.2.1 Johnson?Johnson Corporate Summary
  7.2.2 Johnson?Johnson Business Overview
  7.2.3 Johnson?Johnson Alport Syndrome Treatment Major Product Offerings
  7.2.4 Johnson?Johnson Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Johnson?Johnson Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Alport Syndrome Treatment Major Product Offerings
  7.3.4 Abbott Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 Abbott Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Alport Syndrome Treatment Major Product Offerings
  7.4.4 Sanofi Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Alport Syndrome Treatment Major Product Offerings
  7.5.4 Bayer Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bayer Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Alport Syndrome Treatment Major Product Offerings
  7.6.4 Merck Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Alport Syndrome Treatment Major Product Offerings
  7.7.4 Novartis Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Alport Syndrome Treatment Major Product Offerings
  7.8.4 AstraZeneca Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Eli Lilly and Company
  7.9.1 Eli Lilly and Company Corporate Summary
  7.9.2 Eli Lilly and Company Business Overview
  7.9.3 Eli Lilly and Company Alport Syndrome Treatment Major Product Offerings
  7.9.4 Eli Lilly and Company Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.9.5 Eli Lilly and Company Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Alport Syndrome Treatment Major Product Offerings
  7.10.4 GlaxoSmithKline Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Teva Pharmaceutical Industries
  7.11.1 Teva Pharmaceutical Industries Corporate Summary
  7.11.2 Teva Pharmaceutical Industries Business Overview
  7.11.3 Teva Pharmaceutical Industries Alport Syndrome Treatment Major Product Offerings
  7.11.4 Teva Pharmaceutical Industries Alport Syndrome Treatment Revenue in Global Market (2017-2022)
  7.11.5 Teva Pharmaceutical Industries Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Alport Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Alport Syndrome Treatment Market Drivers in Global Market
Table 3. Alport Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Alport Syndrome Treatment in Global Market
Table 5. Top Alport Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alport Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alport Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alport Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Alport Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alport Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alport Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alport Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alport Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Alport Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alport Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alport Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Alport Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alport Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alport Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alport Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alport Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alport Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alport Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alport Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Alport Syndrome Treatment Product Offerings
Table 32. Pfizer Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Johnson?Johnson Corporate Summary
Table 34. Johnson?Johnson Alport Syndrome Treatment Product Offerings
Table 35. Johnson?Johnson Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Alport Syndrome Treatment Product Offerings
Table 38. Abbott Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Alport Syndrome Treatment Product Offerings
Table 41. Sanofi Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Alport Syndrome Treatment Product Offerings
Table 44. Bayer Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Alport Syndrome Treatment Product Offerings
Table 47. Merck Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Alport Syndrome Treatment Product Offerings
Table 50. Novartis Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Alport Syndrome Treatment Product Offerings
Table 53. AstraZeneca Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Eli Lilly and Company Corporate Summary
Table 55. Eli Lilly and Company Alport Syndrome Treatment Product Offerings
Table 56. Eli Lilly and Company Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Alport Syndrome Treatment Product Offerings
Table 59. GlaxoSmithKline Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Teva Pharmaceutical Industries Corporate Summary
Table 61. Teva Pharmaceutical Industries Alport Syndrome Treatment Product Offerings
Table 62. Teva Pharmaceutical Industries Alport Syndrome Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Alport Syndrome Treatment Segment by Type in 2021
Figure 2. Alport Syndrome Treatment Segment by Application in 2021
Figure 3. Global Alport Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alport Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alport Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alport Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alport Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alport Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson?Johnson Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eli Lilly and Company Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teva Pharmaceutical Industries Alport Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)